Aimei Health Technology (NASDAQ:AFJK) Announces Quarterly Earnings Results

Aimei Health Technology (NASDAQ:AFJK) issued its earnings results on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, FiscalAI reports.

Aimei Health Technology Stock Up 0.4%

Shares of Aimei Health Technology stock traded up $0.05 during trading on Friday, reaching $12.05. The company’s stock had a trading volume of 336 shares, compared to its average volume of 31,850. The firm’s 50-day moving average is $21.33 and its two-hundred day moving average is $32.94. Aimei Health Technology has a 52-week low of $6.75 and a 52-week high of $130.37. The company has a market cap of $38.20 million, a price-to-earnings ratio of 75.32 and a beta of 0.90.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Jane Street Group LLC bought a new position in Aimei Health Technology during the 4th quarter valued at approximately $302,000. Geode Capital Management LLC bought a new position in shares of Aimei Health Technology in the 4th quarter worth approximately $413,000. Quarry LP lifted its stake in shares of Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares during the period. Finally, Clear Street Group Inc. boosted its holdings in Aimei Health Technology by 36.5% in the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after acquiring an additional 22,294 shares in the last quarter. 45.58% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a report on Wednesday, June 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.